Shanghai Pioneer Holding Ltd. is an investment holding company, which engages in the manufacture, promotion, and sale of pharmaceutical products. The company is headquartered in Shanghai, Shanghai and currently employs 343 full-time employees. The company went IPO on 2013-11-05. The firm operates mainly through two segments. The Products Sold via the Provision of Channel Management Services segment is principally engaged in the sales of the Company's ophthalmic pharmaceutical products to customers through pipeline management arrangements. The Products Sold via the Provision of Comprehensive Marketing, Promotion and Channel Management Services segment is principally engaged in the sale of all of the Company's pharmaceutical products and medical devices to customers through comprehensive marketing, promotion and channel management arrangements. The firm mainly conducts its businesses in the domestic market.